Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
Title:
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
Author:
Fassnacht, Martin Berruti, Alfredo Baudin, Eric Demeure, Michael J Gilbert, Jill Haak, Harm Kroiss, Matthias Quinn, David I Hesseltine, Elizabeth Ronchi, Cristina L Terzolo, Massimo Choueiri, Toni K Poondru, Srinivasu Fleege, Tanya Rorig, Ramona Chen, Jihong Stephens, Andrew W Worden, Francis Hammer, Gary D